Physician profile
Johan Reyes
NPI 1750680948
$6,284.46
in general payments reported to CMS, 2019-2025
28 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,947 · 2020: $380 · 2021: $848 · 2022: $358 · 2023: $919 · 2024: $1,437 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,752.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,376.54 | 2019-2024 | Senza |
| Si-Bone, INC. | $770.48 | 2019-2024 | |
| Medtronic, INC. | $609.63 | 2021-2025 | Intellis Adaptivestim, Catalyft Pl Expandable Interbody System, Infinity Occipitocervical Upper Thoracic System |
| Boston Scientific Corporation | $570.57 | 2019-2023 | |
| Mml US, INC. | $319.86 | 2024 | Reactiv8 |
| Nuvasive, INC. | $298.36 | 2019-2022 | |
| Vertos Medical, INC. | $291.67 | 2020-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $264.61 | 2019 | |
| Globus Medical, INC. | $261.85 | 2025 | Senza, Vyrsa V1 |
| Painteq LLC | $183.94 | 2021 | |
| Spinal Elements, INC. | $182.01 | 2024 | |
| Abbott Laboratories | $161.27 | 2020-2025 | Eterna, Proclaim |
| Biotronik Nro, INC. | $151.05 | 2023-2024 | Prospera, Biotronik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $141.30 | 2019-2020 | |
| International Rehabilitative Sciences, INC | $130.86 | 2024 | Rs 4i Plus Sequential Stimulator |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $122.38 | 2019 | |
| Mdd US Operations, LLC | $112.53 | 2019 | |
| Stryker Corporation | $65.63 | 2023 | Prolift, Vitoss |
| Astrazeneca Pharmaceuticals LP | $59.37 | 2019 | |
| Kaleo, INC. | $41.33 | 2019 | |
| Pacira Therapeutics, INC. | $38.67 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.54 | 2019 | |
| Scilex Pharmaceuticals INC. | $27.17 | 2019 | |
| Calyxo, INC. | $22.30 | 2025 | Cvac Aspiration System |
| Bioventus LLC | $15.17 | 2019 | |
| Pfizer INC. | $14.71 | 2019 | |
| Almatica Pharma LLC | $12.08 | 2021 | |
| Sentynl Therapeutics, INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johan Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.